216 related articles for article (PubMed ID: 35287985)
1. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Huang HJ; Yang M; Chen HW; Wang S; Chang CP; Ho TS; Kao YS; Tien SM; Lin HH; Chang PC; Lai YC; Hsiao YP; Liu YL; Chao CH; Anderson R; Yeh TM; Lin YS; Wan SW
Vaccine; 2022 Apr; 40(15):2299-2310. PubMed ID: 35287985
[TBL] [Abstract][Full Text] [Related]
2. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.
Wan SW; Lu YT; Huang CH; Lin CF; Anderson R; Liu HS; Yeh TM; Yen YT; Wu-Hsieh BA; Lin YS
PLoS One; 2014; 9(3):e92495. PubMed ID: 24658118
[TBL] [Abstract][Full Text] [Related]
3. Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity.
Park J; Lee HY; Khai LT; Thuy NTT; Mai LQ; Jang YS
Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32075300
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.
Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS
J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127
[TBL] [Abstract][Full Text] [Related]
5. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
[TBL] [Abstract][Full Text] [Related]
6. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
8. Tests in mice of a dengue vaccine candidate made of chimeric Junin virus-like particles and conserved dengue virus envelope sequences.
Mareze VA; Borio CS; Bilen MF; Fleith R; Mirazo S; Mansur DS; Arbiza J; Lozano ME; Bruña-Romero O
Appl Microbiol Biotechnol; 2016 Jan; 100(1):125-33. PubMed ID: 26386688
[TBL] [Abstract][Full Text] [Related]
9. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
Uno N; Ross TM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757
[TBL] [Abstract][Full Text] [Related]
11. DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice.
García-Machorro J; López-González M; Barrios-Rojas O; Fernández-Pomares C; Sandoval-Montes C; Santos-Argumedo L; Villegas-Sepúlveda N; Gutiérrez-Castañeda B; Cedillo-Barrón L
Hum Vaccin Immunother; 2013 Nov; 9(11):2326-35. PubMed ID: 23880886
[TBL] [Abstract][Full Text] [Related]
12. A bivalent form of nanoparticle-based dengue vaccine stimulated responses that potently eliminate both DENV-2 particles and DENV-2-infected cells.
Seesen M; Jearanaiwitayakul T; Limthongkul J; Midoeng P; Sunintaboon P; Ubol S
Vaccine; 2023 Feb; 41(9):1638-1648. PubMed ID: 36740559
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
[TBL] [Abstract][Full Text] [Related]
14. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
Front Immunol; 2019; 10():1522. PubMed ID: 31333657
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement.
Hughes HR; Crill WD; Chang GJ
Virol J; 2012 Jun; 9():115. PubMed ID: 22709350
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency.
Chen MC; Lin CF; Lei HY; Lin SC; Liu HS; Yeh TM; Anderson R; Lin YS
J Immunol; 2009 Aug; 183(3):1797-803. PubMed ID: 19592650
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
Gelanew T; Poole-Smith BK; Hunsperger E
J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
[TBL] [Abstract][Full Text] [Related]
18. A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice.
He L; Sun W; Yang L; Liu W; Li J
Virol Sin; 2022 Oct; 37(5):746-757. PubMed ID: 35835315
[TBL] [Abstract][Full Text] [Related]
19. Design and production of dengue virus chimeric proteins useful for developing tetravalent vaccines.
Batista ICA; Quinan BR; Rocha Alves ÉA; Jangola STG; Oliveira ES; Colombarolli SG; Ferreira JGG; Rocha ESO; Kroon EG; de Assis RR; de Oliveira JG; Fiuza JA; Calzavara-Silva CE
Vaccine; 2020 Feb; 38(8):2005-2015. PubMed ID: 31982262
[TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
